1
Meegdes, M., Geurts, S.M.E., Erdkamp, F.L.G., Dercksen, M.W., Vriens, B.E.P.J., Aaldering, K.N.A., Pepels, M.J.A.E., Winkel, L.M.H., Teeuwen, N.J.A., Boer, M., Tjan-Heijnen, V.C.G.
Veröffentlicht in: Meegdes , M , Geurts , S M E , Erdkamp , F L G , Dercksen , M W , Vriens , B E P J , Aaldering , K N A , Pepels , M J A E , Winkel , L M H , Teeuwen , N J A , Boer , M & Tjan-Heijnen , V C G 2022 , ' The implementation of CDK 4/6 inhibitors and its impact on treatment choices in HR+/HER2-advanced breast cancer patients: A study of the Dutch SONABRE Registry ' , International Journal of Cancer , vol. 150 , no. 1 , pp. 124-131 . https://doi.org/10.1002/ijc.33785;
2022
Veröffentlicht in: Meegdes , M , Geurts , S M E , Erdkamp , F L G , Dercksen , M W , Vriens , B E P J , Aaldering , K N A , Pepels , M J A E , Winkel , L M H , Teeuwen , N J A , Boer , M & Tjan-Heijnen , V C G 2022 , ' The implementation of CDK 4/6 inhibitors and its impact on treatment choices in HR+/HER2-advanced breast cancer patients: A study of the Dutch SONABRE Registry ' , International Journal of Cancer , vol. 150 , no. 1 , pp. 124-131 . https://doi.org/10.1002/ijc.33785;
2022
2
Geurts, S.M.E., Ibragimova, K., Meegdes, M., Erdkamp, F.L.G., Heijns, J.B., Tol, J., Vriens, B.E.P.J., Dercksen, W., Aaldering, K.N.A., Pepels, M.J.A.E., Winkel, L.V.D., Peters, N., van de Wouw, A.J., Hochstenbach, A., De Boer, M., Tjan-Heijnen, V.C.G.
Veröffentlicht in: Annals of Oncology ; volume 33, page S210 ; ISSN 0923-7534;
2022
Veröffentlicht in: Annals of Oncology ; volume 33, page S210 ; ISSN 0923-7534;
2022
3
Pouwels, X. G. L. V., Geurts, S. M. E., Ramaekers, B. L. T., Erdkamp, F., Vriens, B. E. P. J., Aaldering, K. N. A., van de Wouw, A. J., Dercksen, M. W., Smilde, T. J., Peters, N. A. J. B., Riel, J. M. van, Pepels, M. J., Heijnen-Mommers, J., Joore, M. A., Tjan-Heijnen, V. C. G., de Boer, M.
Veröffentlicht in: Pouwels , X G L V , Geurts , S M E , Ramaekers , B L T , Erdkamp , F , Vriens , B E P J , Aaldering , K N A , van de Wouw , A J , Dercksen , M W , Smilde , T J , Peters , N A J B , Riel , J M V , Pepels , M J , Heijnen-Mommers , J , Joore , M A , Tjan-Heijnen , V C G & de Boer , M 2020 , ' The relative effectiveness of eribulin for advanced breast cancer treatment : a study of the southeast Netherlands advanced breast cancer registry ' , Acta Oncologica , vol. 59 , no. 1 , pp. 82-89 . https://doi.org/10.1080/0284186X.2019.1670356;
2020
Veröffentlicht in: Pouwels , X G L V , Geurts , S M E , Ramaekers , B L T , Erdkamp , F , Vriens , B E P J , Aaldering , K N A , van de Wouw , A J , Dercksen , M W , Smilde , T J , Peters , N A J B , Riel , J M V , Pepels , M J , Heijnen-Mommers , J , Joore , M A , Tjan-Heijnen , V C G & de Boer , M 2020 , ' The relative effectiveness of eribulin for advanced breast cancer treatment : a study of the southeast Netherlands advanced breast cancer registry ' , Acta Oncologica , vol. 59 , no. 1 , pp. 82-89 . https://doi.org/10.1080/0284186X.2019.1670356;
2020